Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.
Mounjaro (tirzepatide) injection is now available at Medrocs Pharmacy.
Mounjaro is an injectable medication used as Once-Weekly injection, comes in a single dose Pen.
Read the Instructions for Use included with your pen.
Mounjaro Pen is available in Multiple Dosages.
Let your doctor know how you’re doing on the 2.5-mg and 5-mg doses during your checkup. Once you reach 5 mg, your doctor may keep you at the same dose for longer than 4 weeks. You’ll work together to decide if your dose needs to be increased beyond 5 mg.
Safety and effectiveness of Mounjaro have not been established and use is not recommended in patients less than 18 years of age.
FDA Approval link
FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes